These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9207856)
1. The vitamin D receptor--structure and transcriptional activation. Strugnell SA; Deluca HF Proc Soc Exp Biol Med; 1997 Jul; 215(3):223-8. PubMed ID: 9207856 [TBL] [Abstract][Full Text] [Related]
2. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895 [TBL] [Abstract][Full Text] [Related]
3. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. Herdick M; Carlberg C J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027 [TBL] [Abstract][Full Text] [Related]
4. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369 [TBL] [Abstract][Full Text] [Related]
6. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883 [TBL] [Abstract][Full Text] [Related]
7. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view. Carlberg C; Molnár F Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777 [TBL] [Abstract][Full Text] [Related]
9. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention. Dimitrov V; Salehi-Tabar R; An BS; White JH J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():74-80. PubMed ID: 23911725 [TBL] [Abstract][Full Text] [Related]
10. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs. Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639 [TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Haussler MR; Jurutka PW; Mizwicki M; Norman AW Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797 [TBL] [Abstract][Full Text] [Related]
13. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
14. Identification of an autonomous transactivation domain in helix H3 of the vitamin D receptor. Kraichely DM; Nakai YD; MacDonald PN J Cell Biochem; 1999 Oct; 75(1):82-92. PubMed ID: 10462707 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function. Farmer PK; He X; Schmitz ML; Rubin J; Nanes MS Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E213-20. PubMed ID: 10893342 [TBL] [Abstract][Full Text] [Related]
16. HDX reveals the conformational dynamics of DNA sequence specific VDR co-activator interactions. Zheng J; Chang MR; Stites RE; Wang Y; Bruning JB; Pascal BD; Novick SJ; Garcia-Ordonez RD; Stayrook KR; Chalmers MJ; Dodge JA; Griffin PR Nat Commun; 2017 Oct; 8(1):923. PubMed ID: 29030554 [TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
19. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation through the vitamin D receptor in osteoblasts. Kraichely DM; MacDonald PN Front Biosci; 1998 Aug; 3():d821-33. PubMed ID: 9682036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]